Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Aeolus' AEOL-10150 protects lungs against chlorine gas exposure in animal studies

Nov. 6, 2009

Nabi Biopharmaceuticals starts phase III trial of NicVAX as an aid to stop smoking

Nov. 5, 2009

Nabi Biopharmaceuticals takes part in phase IIb study of NicVAX vaccine

Oct. 29, 2009

Aeolus drug protects gastrointestinal tract in acute radiation syndrome studies

Oct. 26, 2009

Non-selective opioid modulator RDC-5768 reduces behavioral effects of drugs of abuse

Oct. 23, 2009

Novartis reports interim results from phase II trial of Cytos Biotechnology's nicotine vaccine

Oct. 21, 2009

Alkermes reports results from clinical trials of ALKS-33

Oct. 14, 2009

Catalyst to continue development of vigabatrin for cocaine and methamphetamine addiction

Oct. 5, 2009

NIH awards Novelos Therapeutics and MGH grant to study NOV-002 and NOV-205

Oct. 2, 2009

NIAID awards Cleveland BioLabs grant for protectan CBLB-502 research

Sep. 29, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 7, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...